Opinion · Supreme Court of the United States
Stamps v. Collagen Corp
510 U.S. 824
- Type
- Opinion
- Court
- Supreme Court of the United States
- Jurisdiction
- Federal
- Date
- 1993-10-04
- Topic
- general
How later courts describe this case
- holding that existence of express preemption clause precludes reliance on implied preemption doctrine, without determining whether provision constituted a "reliable indicium of congressional intent"
- holding that the analysis used in Ferebee did not survive the Cipollone decision
- holding that the analysis used in Fer-ebee did not survive the Cipollone decision
- finding that the express preemption provision in the MDA precludes any discussion regarding implied preemption
- holding state law claims not preempted where FDA had established no specific requirements unique to the Class III medical device at issue
- finding that the PMA process constitutes a “specific requirement” applicable to a particular device
- “[W]e do not believe the [preemption] analysis [in Ferebee] can be said to have survived Cipollone-”
- claims of failure to warn and defective design preempted where manufacturer of Class III device underwent PMA
Citator
UpLaw has not yet analyzed Stamps v. Collagen Corp. The absence of a flag is not a finding that it is good law.
- Cited by
- 94 opinions
Stamps
v.
Collagen Corp.
No. 92-1989.
Supreme Court of United States.
October 4, 1993.
1
Appeal from the C. A. 5th Cir.
2
Certiorari denied. Reported below: 984 F. 2d 1416.